High-performance liquid chromatographic method for the determination of 4′-(9-acridinylamino)methanesulfon-m-anisidide in plasma
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 276 (2) , 367-374
- https://doi.org/10.1016/s0378-4347(00)85103-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- PHASE-II STUDY OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE (NSC 249992) IN CHILDREN WITH ACUTE-LEUKEMIA AND LYMPHOMA1982
- Identification of conjugation and cleavage products in the thiolytic metabolism of the anticancer drug 4′-(9-acridinylamino)methanesulfon-m-anisidideJournal of Mass Spectrometry, 1981
- Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disordersBlood, 1981
- INITIAL EXPERIENCE WITH AMSA AS SINGLE AGENT TREATMENT AGAINST MALIGNANT LYMPHOPROLIFERATIVE DISORDERS1981
- Gas-chromatographic determination of amsacrine (AMSA) in plasmaAnalytical and Bioanalytical Chemistry, 1981
- 4′-(9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA): A New Drug Effective in the Treatment of Adult Acute LeukemiaAnnals of Internal Medicine, 1980
- PHASE-I AND PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN PATIENTS WITH ACUTE-LEUKEMIA1980
- A fluorescence assay for 4′-(9-acridinylamino)methanesulfon-m-anisidide, a new antitumor agentAnalytical Biochemistry, 1979
- Thiolytic cleavage of the anti-tumour compound 4′-(9-acridinylamino)-methanesulphon-m-anisidine (m-AMSA, NSC 156 303) in bloodChemico-Biological Interactions, 1977